ThermiVa treatments have already proven to be effective and I’m eager to work with the team to bring this first-of-its kind technology into the women’s health arena.
Southlake, TX (PRWEB) March 19, 2015
ThermiGyn, a newly announced company that provides advanced technology using finely controlled thermal energy to non-surgically treat gynecological conditions, is pleased to announce the appointment of Jackie Gonzalez as Chair of their Women’s Health Business Advisory Board. Gonzalez will spearhead the company’s expansion to address a broad range of women’s health initiatives. A veteran executive in sales, marketing and business development, Gonzalez formerly led medical specialty sales teams for erectile dysfunction and breast cancer risk reduction.
“Jackie has over 20 years’ experience in leading organizations from start-up to acquisition” says Paul Herchman, Chief Executive Officer of ThermiHealth. “She brings a tremendous breadth of knowledge and experience to our team.”
ThermiGyn just launched the eagerly anticipated ThermiVa, a unique, temperature controlled, non-surgical radiofrequency treatment using the science of heat for medical and aesthetic applications. ThermiVa is currently being studied for improvement in the sensation of vaginal laxity caused by childbirth or aging. The current market for vaginal tightening in the US alone is a projected to be approximately a staggering $2.4 billion. To date, approximately 55 patients have been treated using the ThermiGyn temperature controlled radio frequency technology. Early results show that nearly all participants experienced a noticeable improvement after one treatment. Secondarily, researchers have noted that in many cases, there was also improvement in urinary incontinence.
Gonzalez commented, “ThermiVa treatments have already proven to be effective and I’m eager to work with the team to bring this first-of-its kind technology into the women’s health arena. This underreported condition affects millions of women, and often impacts their relationships. We are excited to be launching a technology that effectively addresses this sensitive issue using a comfortable treatment, without the need for surgery.”
ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform promotes increased patient safety and clinical effectiveness while providing versatile micro-invasive and non-invasive solutions for OB-GYNs serving the women’s health marketplace. ThermiVa is a daughter product to the ThermiHealth flagship product, the ThermiRF Temperature Controlled Radio Frequency Generator System, and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis; and to create lesions in nervous tissue. ThermiRF is an advanced technology using finely controlled thermal energy. It is a multi-use platform, which promotes increased patient safety and clinical effectiveness while providing versatile solutions for physicians serving the medical and aesthetic market.
For more information about ThermiGyn, please visit http://www.thermi.com.